tiprankstipranks
Acutaas Chemicals Ltd (IN:ACUTAAS)
:ACUTAAS
India Market
Want to see IN:ACUTAAS full AI Analyst Report?

Acutaas Chemicals (ACUTAAS) Price & Analysis

4 Followers

ACUTAAS Stock Chart & Stats

₹1747.20
-₹131.70(-5.63%)
At close: 4:00 PM EST
₹1747.20
-₹131.70(-5.63%)

Bulls Say, Bears Say

Bulls Say
Strong Recent Revenue Growth And MarginsA sharp FY2026 revenue acceleration (~52%) with materially higher EBIT and net margins indicates stronger pricing power, improved product mix and operating leverage. These durable improvements support sustainable earnings capacity if the firm maintains execution and market share over the medium term.
Very Low Leverage And Stronger ROEThe company's conservatively positioned balance sheet with minimal debt and a rising return on equity (~21.5%) enhances financial flexibility. Low leverage reduces default and refinancing risk, enabling sustainable capital allocation for growth, R&D or opportunistic M&A without immediate stress on cash flows.
Improved Operating Cash GenerationOperating cash flow strengthened notably to ~3.0B and covered reported earnings in FY2026, demonstrating underlying cash-generating improvements in core operations. Better OCF reduces short-term liquidity strain and supports reinvestment, working-capital needs and debt servicing capacity over coming quarters.
Bears Say
Persistent Negative Free Cash FlowConsistent negative free cash flow, including ~-0.29B in FY2026, signals that capital expenditures or working-capital demands outpace operating cash generation. Over time this constrains the ability to fund dividends, buybacks or reduce leverage without external financing, limiting financial optionality.
Volatile Operating Cash Flow HistoryHistorical volatility in operating cash flow, including a negative OCF year (FY2022), highlights earnings quality and working-capital sensitivity. Such swings complicate forecasting, heighten liquidity risk during sector cycles, and can force reactive financing or curtailed investments.
Prior Leverage Spike And Earnings SensitivityA past spike in debt-to-equity (~0.32 in FY2024) paired with a sharp margin drop that year shows capital-structure and earnings sensitivity to shocks. This non-uniform stability raises the risk that adverse cycles or execution missteps could force higher leverage or margin compression again.

ACUTAAS FAQ

What was Acutaas Chemicals Ltd’s price range in the past 12 months?
Acutaas Chemicals Ltd lowest stock price was ₹1059.05 and its highest was ₹2743.55 in the past 12 months.
    What is Acutaas Chemicals Ltd’s market cap?
    Acutaas Chemicals Ltd’s market cap is ₹219.63B.
      When is Acutaas Chemicals Ltd’s upcoming earnings report date?
      Acutaas Chemicals Ltd’s upcoming earnings report date is Aug 06, 2026 which is in 91 days.
        How were Acutaas Chemicals Ltd’s earnings last quarter?
        Acutaas Chemicals Ltd released its earnings results on Apr 30, 2026. The company reported ₹16.1 earnings per share for the quarter, beating the consensus estimate of ₹13.05 by ₹3.05.
          Is Acutaas Chemicals Ltd overvalued?
          According to Wall Street analysts Acutaas Chemicals Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Acutaas Chemicals Ltd pay dividends?
            Acutaas Chemicals Ltd pays a Annually dividend of ₹1.5 which represents an annual dividend yield of 0.09%. See more information on Acutaas Chemicals Ltd dividends here
              What is Acutaas Chemicals Ltd’s EPS estimate?
              Acutaas Chemicals Ltd’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Acutaas Chemicals Ltd have?
              Acutaas Chemicals Ltd has 81,871,124 shares outstanding.
                What happened to Acutaas Chemicals Ltd’s price movement after its last earnings report?
                Acutaas Chemicals Ltd reported an EPS of ₹16.1 in its last earnings report, beating expectations of ₹13.05. Following the earnings report the stock price went up 3.841%.
                  Which hedge fund is a major shareholder of Acutaas Chemicals Ltd?
                  Currently, no hedge funds are holding shares in IN:ACUTAAS
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Acutaas Chemicals Ltd

                    Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications. It also provides specialty chemicals for use in battery chemicals, personal care, agrochemicals, coatings, electronics, and industrial processes; photoresist chemicals to semiconductor applications; electrolyte additives for lithium battery cells; and parabens, methyl salicylate, and other commodity chemicals for cosmetics, agrochemicals, and fine chemicals. The company was formerly known as Ami Organics Limited and changed its name to Acutaas Chemicals Limited in May 2025. Acutaas Chemicals Limited was founded in 2004 and is based in Surat, India.

                    Acutaas Chemicals (ACUTAAS) Earnings & Revenues

                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Alkyl Amines Chemicals Limited
                    Anupam Rasayan India Ltd.
                    Balaji Amines Limited
                    HEG Limited
                    Rallis India Limited
                    Popular Stocks